AuryzoN: 2020 Updates
ReconstratA has received a Notice of Allowance from the United States Patent and Trademark Office for the AuryzoN platform!
Thanks to the incredibly generous work of our technical partners at Advanced Sterilization Products (ASP), AuryzoN and its companion device DimensioN have passed cleaning and sterilization trials for safe and reproducible use in the operating room.
The AuryzoN platform is poised to initiate clinical trials with our collaborating institution, the Johns Hopkins Hospital in Baltimore, MD.
For further information, please refer to our study on ClinicalTrials.gov in the link below:
ReconstratA has received a Notice of Allowance from the United States Patent and Trademark Office for the AuryzoN platform!
Thanks to the incredibly generous work of our technical partners at Advanced Sterilization Products (ASP), AuryzoN and its companion device DimensioN have passed cleaning and sterilization trials for safe and reproducible use in the operating room.
The AuryzoN platform is poised to initiate clinical trials with our collaborating institution, the Johns Hopkins Hospital in Baltimore, MD.
For further information, please refer to our study on ClinicalTrials.gov in the link below:
Our missionMillions of patients across the world can benefit from ear and nose reconstruction, necessitated by traumatic injury, cancer resection, or birth defects.
We believe everyone should have access to these life-changing surgeries. |